Cost-effectiveness analysis of preventing mother-to-child transmission of hepatitis B by injecting hepatitis B immune globulin

European Journal of Gastroenterology and Hepatology

Volumn 24, Issue 12, 2012, Pages 1363-1369

  Guo, Yan ^a,b   Zhang, Wei ^d   Zhang, Yu ^a   Lin, Xiaofang ^a   Zhang, Bin ^c   Chen, Chong ^c   Du, Yukai ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b Wuhan Centers for Disease Prevention and Control   (China)

^c 302 MILITARY HOSPITAL   (China)

^d Wuhan Medical Care Center for Women and Children   (China)

Author keywords

cost effectiveness analysis; hepatitis B; hepatitis B immunoglobulin; mother to child transmission

Indexed keywords

HEPATITIS B ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE;

ACTIVE IMMUNIZATION; ADULT; ARTICLE; CHILD HEALTH; CHINA; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; ECONOMIC ASPECT; FEMALE; FOLLOW UP; HEPATITIS B; HUMAN; MAJOR CLINICAL STUDY; MATERNAL WELFARE; NEWBORN; OUTCOME ASSESSMENT; PASSIVE IMMUNIZATION; PRENATAL CARE; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY ADJUSTED LIFE YEAR; RANDOM SAMPLE; VERTICAL TRANSMISSION; VIRUS TRANSMISSION;

BIOLOGICAL MARKERS; CHI-SQUARE DISTRIBUTION; CHINA; COST-BENEFIT ANALYSIS; DRUG COSTS; FEMALE; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VACCINES; HEPATITIS B, CHRONIC; HUMANS; IMMUNOGLOBULINS; INFANT; INFANT, NEWBORN; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; MODELS, ECONOMIC; ODDS RATIO; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PRENATAL CARE; PROSPECTIVE STUDIES; TIME FACTORS; VACCINATION;

EID: 84869501714     PISSN: 0954691X     EISSN: 14735687     Source Type: Journal    
DOI: 10.1097/MEG.0b013e32835847c6     Document Type: Article

References (34)

1. WHO. Hepatitis B surveillance and control. Geneva, Switzerland: World Health Organization. Available at: http://www.who.int/about/contacthq/en/ index.html; 2009.
2. Liang XF, Chen YS, Wang XJ, He X, Chen LJ, Wang J, et al. A study on the sero-epidemiology of hepatitis B in Chinese population aged over 3-years old. Chin J Epidemiol 2005; 26:655-658.
3. Zheng PY, Zhang DY, Lu GF, Yang PC, Qi YM, Wang BS. Effects of lamivudine on the function of dendritic cells derived from patients with chronic hepatitis B virus infection. World J Gastroenterol 2007; 13:4641-4645.
4. Shi Z, Li X, Yang Y, Ma L, Schreiber A. Obstetrical management of fulminant viral hepatitis in late pregnancy. Reprod Sys Sex Disord 2012; 1:1.
5. Halliday J, Lokan J, Angus PW, Gow P. A case of fulminant hepatic failure in pregnancy. Hepatology 2010; 51:341-342.
6. Koedijk FD, op de Coul EL, Boot HJ, van de Laar MJ. Hepatitis B surveillance in the Netherlands, 2002-2005: acute infection is mainly via sexual contact while chronic infection is via vertical transmission through mothers from endemic regions. Ned Tijdschr Geneeskd 2007; 151:2389-2394.
7. Wang JS, Zhu QR. A long-term follow-up of hepatitis B vaccine inoculated and HB immunoglobulin combinely immunized infants born to HBsAg positive mothers. Zhonghua Liu Xing Bing Xue Za Zhi 2001; 7:96-99.
8. Hsu EK, Murray KF. Hepatitis B and C in children. Nat Clin Pract Gastroenterol Hepatol 2008; 5:311-320.
9. Jia JD, Zhuang H. The overview of the seminar on chronic hepatitis B. Zhonghua Gan Zang Bing Za Zhi 2004; 12:698-699.
10. Kanwal F, Gralnek IM, Martin P, Dulai GS, Farid M, Spiegel BM. Treatment alternatives for chronic hepatitis B virus infection: a cost-effectiveness analysis. Ann Int Med 2005; 142:821-831.
11. Shao ZJ, Zhang L, Xu JQ, Xu DZ, Men K, Zhang JX, et al. Mother-to-infant transmission of hepatitis B virus: a Chinese experience. J Med Virol 2011; 83:791-795.
12. Xiao XM, Li AZ, Chen X, Zhu YK, Miao J. Prevention of vertical hepatitis B transmission by hepatitis B immunoglobulin in the third trimester of pregnancy. Int J Gynaecol Obstet 2007; 96:167-170.
13. Li T. Analysis of the blocking effect of mother-to-child transmission of hepatitis B by combined immunization on pregnant women and infants. Huaxia Med 2007; 20:498-499.
14. Shi Z, Li X, Ma L, Yang Y. Hepatitis B immunoglobulin injection in pregnancy to interrupt hepatitis B virus mother-to-child transmission-a meta-analysis. Int J Infect Dis 2010; 14:e622-e634.
15. Guo Y, Liu J, Meng L, Meina H, Du Y. Survey of HBsAg-positive pregnant women and their infants regarding measures to prevent maternal-infantile transmission. BMC Infect Dis 2010; 10:26.
16. Society of Infectious Diseases, Chinese Society of Hepatology. Viral hepatitis control programme. Chin J Infectious Dis 2001; 19: 56-62.
17. Liu YP, Shao ZJ, Xu DZ. Study on the blocking effect of injecting HBsAg positive mothers during pregnancy and their infants at birth with HB immunoglobulin on mother-to-infant transmission of HBV. Chin J Dis Control Prev 2004; 8:109-110.
18. Shao ZJ, Xu DZ, Xu JQ, Li JH, Yan YP, Men K, et al. Maternal hepatitis B virus (HBV) DNA positivity and sexual intercourse are associated with HBV intrauterine transmission in China: a prospective case-control study. J Gastroenterol Hepatl 2007; 22:165-170.
19. Wu GY, Gong YL, Yu SL, Shao RT, Qin HJ. Study on the cost-effectiveness, benefit and utility analysis on the infant inoculation hepatitis B vaccine in Shanghai. Zhonghua Liu Xing Bing Xue Za Zhi 2004; 25:474-478.
20. Yu SL, Gong YL, Shao RT, Wu GY. Study on burden of diseases of chronic hepatitis B, virrhosis and liver cancer caused by hepatitis B virus. Chin J Public Health 2003; 19:280-282.
21. Xu Q, Xiao L, Lu XB, Zhang YX, Cai X. A randomized controlled clinical trial: interruption of intrauterine transmission of hepatitis B virus infection with HBIG. World J Gastroenterol 2006; 12:3434-3437.
22. Liu CB, Su CA. Notions about hepatitis B immunoglobulin on the blocking of mother-to-child perinatal transmission. Chin Planned Immun 2006; 12:148-150.
23. Yang J, Zeng XM, Men YL, Zhao LS. Elective caesarean section versus vaginal delivery for preventing mother to child transmission of hepatitis B virus - a systematic review. Virol J 2008; 5:100.
24. Lebray P. Assisted reproductive techniques in hepatitis B or C infection: role of the hepatologist. Gynecol Obstet Fertil 2007; 35:1025-1029.
25. Shi Z, Yang Y, Wang H, Ma L, Schreiber A, Li XM, et al. Breastfeeding of newborns by mothers carrying hepatitis B virus: a meta-analysis and systematic review. Arch Pediatr Adolesc Med 2011; 165: 837-846.
26. Singh AE, Plitt SS, Osiowy C, Surynicz K, Kouadjo E, Preiksaitis J, et al. Factors associated with vaccine failure and vertical transmission of hepatitis B among a cohort of Canadian mothers and infants. J Viral Hepat 2011; 18: 468-473.
27. Zhang SL, Yue YF, Bai GQ, Shi L, Jiang H. Mechanism of intrauterine infection of hepatitis B virus. World J Gastroenterol 2004; 10:437-438.
28. Shao ZJ, Li JH, Xu DZ, Jiang QW, Xu JQ. Association of administration of hepatitis B immunoglobulin during pregnancy with intrauterine infection of HBV. Chin J Public Health 2008; 24:135-136.
29. Lu HY, Zhou H, Zhao WY, Zhang RH, Chen JH. Effect observation of using hepatitis B immunoglobulin by pregnant women to block vertical transmission of hepatitis B virus. Matern Child Health Care China 2007; 22:1335-1337.
30. Yuan J, Lin J, Xu A, Li H, Hu B, Chen J, et al. Antepartum immunoprophylaxis of three doses of hepatitis B immunoglobulin is not effective: a single-centre randomized study. J Viral Hepatitis 2006; 13:597-604.
31. Koyama T, Matsuda I, Sato S, Yoshizawa H. Prevention of perinatal hepatitis B virus transmission by combined passive-active immunoprophylaxis in Iwate, Japan (1981-1992) and epidemiological evidence for its efficacy. Hepatol Res 2003; 26:287-292.
32. Zeng DX. Intervention on psychological state and health knowledge needs of pregnant women carrying hepatitis B virus. Matern Child Health Care China 2007; 22:4372-4374.
33. Read JS, Cannon MJ, Stanberry LR, Schuval S. Prevention of motherto- child transmission of viral infections. Curr Probl Pediatr Adolesc Health Care 2008; 38:274-297.
34. Qi YL,Wang FZ, Gong XH, Pan L, Zeng XJ, Li H. Analysis on cost-benefit for infant hepatitis B vaccine immunization strategy in Beijing. Chin J Public Health 2004; 20:1067-1069.